Skip to main content
Clinical Trials/NL-OMON44524
NL-OMON44524
Completed
Not Applicable

Population pharmacokinetics and pharmacodynamics of sorafenib in hepatocellular carcinoma patients with Child Pugh B liver cirrhosis - Sorafenib pharmacokinetics in Child Pugh B liver cirrhosis (SORBE)

Academisch Medisch Centrum0 sites45 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
hepatocellular carcinoma
Sponsor
Academisch Medisch Centrum
Enrollment
45
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • advanced hepatocelllar carcinoma (HCC) \- BCLC stage C
  • Child Pugh(CP)\-B liver cirrhosis (CP\-B score 7 or 8\)

Exclusion Criteria

  • Child Pugh\-B9 liver cirrhosis
  • Child Pugh\-C liver cirrhosis
  • Concurrent antitumoral treatment for HCC or other malignancies

Outcomes

Primary Outcomes

Not specified

Similar Trials